Ordering
Available Variants1 mg
CHA.90242-1mg
Price
€216.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 mg | CHA.90242-1mg | €216.00 |
≥97% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C50H67N11O11S2 |
|---|---|
| CAS Number | 103429-31-8 |
| Molecular Weight | 1062.26 |
| NACRES | NA.77 |
| PubChem Substance ID | 329820226 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD00076708 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
CTOP, also known as CAS 103429-31-8, is a synthetic compound that has garnered significant attention in the scientific community due to its unique properties and potential applications. As a chemical entity, CTOP exhibits distinct molecular characteristics that enable it to interact with specific biological targets, thereby modulating various physiological processes. Research has shown that CTOP can act as a potent and selective antagonist, binding to specific receptors and influencing downstream signaling pathways. The compounds mechanism of action is complex and multifaceted, involving intricate molecular interactions that ultimately impact cellular function and behavior. Further studies are necessary to fully elucidate the effects of CTOP and explore its potential therapeutic utility, particularly in the context of treating diseases and disorders associated with dysregulated receptor activity.
